HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden
Genes · 18.11.2026 · 17 (11) · 1460
DOI: 10.3390/genes17111460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 18.11.2026. Verfasst von Tiago Paixão und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Foundation for the Study of Diabetes, Maratona da Saude, Fundação para a Ciência e Tecnologia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Whether age at type 1 diabetes (T1D) diagnosis reflects overall HLA class II epitope burden or additional sequence information remains unclear. We investigated whether HLA-DRB1 β57, a position in HLA-DR distinct from the established DQB1 β57 susceptibility position in HLA-DQ, contributes information about age at diagnosis beyond class II epitope burden.
Methods
Phased DRB1–DQA1–DQB1 data were analysed in 97 early-onset T1D patients (EOT1D; ≤5 years) and 96 later-onset patients (LaOT1D; 8–30 years), recruited specifically within these age groups, and 169 controls from Portugal. Analyses included burden-adjusted multinomial models, complementary continuous-age regression, natural DRB1*04 sequence comparisons, and repeated nested cross-validation with independently tuned leave-one-position-out ablations; log loss was the primary cross-validation metric.
Results
Epitope burdens distinguished T1D from controls but showed no statistically supported difference between EOT1D and LaOT1D. Adding DRB1 β57D improved multinomial fit (p = 2.28 × 10−8); the adjusted EOT1D-versus-LaOT1D relative risk ratio was 3.17 per copy (95% CI 1.65–6.09). DRB1 β57D dosage correlated inversely with age at diagnosis (ρ = −0.231; p = 0.0012) and was associated with diagnosis 2.28 years earlier per copy in the adjusted continuous-age model (95% CI −4.17 to −0.38; p = 0.0187). Expanded natural DRB1*04 comparisons involved β57, β71 and β86. Removing β57 increased cross-validated log loss by 0.0783 (Benjamini–Hochberg-adjusted q = 0.028) and reduced the area under the receiver operating characteristic curve from 0.6643 to 0.5134; no other removal survived correction in the primary patient comparison. Adjusted subgroup analyses did not establish an association after excluding *04:08/*04:05 carriers or among non-DR4 participants.
Conclusions
Within this Portuguese cohort, DRB1 β57 contributed information about age at T1D diagnosis beyond the specified class II epitope burdens. These findings refine the previously observed DRB1*04 allele associations and warrant independent replication and functional investigation.
Förderung
- European Foundation for the Study of Diabetes
- Maratona da Saude
- Fundação para a Ciência e Tecnologia
Zitieren
APA
Paixão, T., Matoso, P., Sobral, D., Ligeiro, D., Fitas, A. L., Limbert, C., Penha-Gonçalves, C., Demengeot, J., & Caramalho, I. (2026). HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden. Genes, 17(11), 1460. https://doi.org/10.3390/genes17111460
Vancouver
Paixão T, Matoso P, Sobral D, Ligeiro D, Fitas AL, Limbert C, et al. HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden. Genes. 2026;17(11):1460. doi:10.3390/genes17111460
BibTeX
@article{Paixo2026,
author = {Paixão, Tiago and Matoso, Paula and Sobral, Daniel and Ligeiro, Dário and Fitas, Ana Laura and Limbert, Catarina and Penha-Gonçalves, Carlos and Demengeot, Jocelyne and Caramalho, Iris},
title = {HLA-DRB1 Position 57 Is Associated with Age at Type 1 Diabetes Diagnosis Beyond Class II Susceptibility Burden},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1460},
doi = {10.3390/genes17111460}
}
EUVIMED